IMD Telemetry Authorization to Prevent Battery Drain

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Implantable medical devices (IMDs) face challenges with telemetry overuse due to unauthorized devices initiating sessions, leading to premature battery depletion, which is a hurdle in achieving efficient power management and extending the lifespan of these devices.

Innovation Solution

Implantable devices are equipped with authorization components to determine if external devices are authorized, disabling telemetry connections with unauthorized devices and regulating communication to prevent battery drainage, using protocols like Bluetooth Low Energy (BLE) and tracking telemetry usage to manage power consumption.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If telemetry communication is enabled between implantable device and external devices, then monitoring and data exchange capabilities are improved, but power source lifespan deteriorates due to unauthorized devices depleting the battery

Engineering Contradiction:
Improvetelemetry communication capabilityVSAvoidpower source lifespan
Core Design Contradiction:
Adaptability or versatilityVSDuration of action of stationary object

Solution Approach 1:

The patent applies preliminary action by establishing an authorization mechanism before telemetry communication occurs. The implantable device pre-configures authorized external devices through a pairing process, storing their identifiers in memory. This preliminary authorization prevents unauthorized devices from initiating telemetry sessions that would drain the battery, thus protecting power source lifespan while maintaining telemetry functionality with legitimate devices.

Inventive Principle:
Principle #10Preliminary action

2Loss of information

If telemetry connection is established with external devices, then data exchange is improved, but power consumption increases leading to battery drainage

Engineering Contradiction:
Improvedata exchange capabilityVSAvoidpower consumption
Core Design Contradiction:
Loss of informationVSUse of energy by moving object

Solution Approach 1:

The patent implements feedback by continuously monitoring telemetry session status and authorization credentials. The implantable device checks whether each incoming telemetry request comes from an authorized device stored in memory, and terminates sessions that exceed predefined parameters. This feedback mechanism ensures data exchange occurs only with authorized devices and within safe energy consumption limits, preventing unnecessary battery drainage while maintaining essential communication.

Inventive Principle:
Principle #23Feedback

3Ease of operation

If device allows public telemetry protocols, then ease of operation is improved, but security deteriorates allowing unauthorized access

Engineering Contradiction:
Improvetelemetry accessibilityVSAvoidsecurity against unauthorized access
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent uses an intermediary approach by introducing an authorization layer between the public telemetry protocol and the implantable device's internal systems. External devices must present valid authorization credentials (device identifiers, cryptographic keys) stored during a controlled pairing process. The implantable device verifies these credentials before establishing telemetry sessions, acting as a gatekeeper that allows easy access for authorized devices while blocking unauthorized access attempts.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12611543B2Telemetry overuse reduction in a medical device
Publication Date: 2026.04.28 MEDTRONIC INC
  • US12611543B2 patent drawing
  • US12611543B2 patent drawing
  • US12611543B2 patent drawing

AI summary

Systems, apparatus, methods and computer-readable storage media facilitating telemetry overuse reduction in a medical device, such as an implantable medical device (“IMD”) are provided. In one embodiment, an IMD includes a housing configured to be implanted at least partially within a patient, a memory and circuitry within the housing and a processor that executes executable components stored in the memory. The executable components include: a communication component configured to establish a telemetry connection with an external device to communicate data associated with sensed physiological data or therapy; and an authorization component configured to determine whether the external device is authorized to communicate with the IMD, wherein the communication component is further configured to disable the telemetry connection with the external device and prevent additional communication with the external device for a defined period of time based on a determination that the external device fails to be authorized to communicate with the IMD.